Skip to main content
TipRanks
Go Ultimate75% OFF

Japan Animal Referral Medical Center Co., Ltd. (6039) AI Stock Analysis

0 Followers
JP:6039

Japan Animal Referral Medical Center Co., Ltd.

(TSE/TYO:6039)

Select Model
Rating:60Neutral
Price Target:JPY 992.00â–²(5.64% Upside)
Action:reiterated
Date:11/07/26

Japan Animal Referral Medical Center scores moderately. The strongest support comes from fundamentals: rapid revenue growth, a projected 60% surge in FY2026 earnings, and an attractive 12.4x P/E with a 1.4% dividend yield. Offsetting this, the stock is in a pronounced downtrend, trading far below all key moving averages with negative MACD and weak momentum readings. Financially, the main risks are capital intensity and funding: free cash flow has been repeatedly negative and is projected at -¥953M in FY2026, while debt is set to climb to ¥5.16B, leaving execution on expansion investments as the key determinant of future performance.

Positive Factors
Sustained Revenue GrowthRevenue has more than doubled across the reported period and continued growing in FY2026, indicating sustained demand for the company’s specialized referral veterinary services. Continued top-line expansion can support investment in facilities, equipment, and specialist capacity while strengthening its position in advanced companion-animal care.
Negative Factors
Free-Cash-Flow DeficitThe sharp move to negative free cash flow means operating performance is not currently translating into discretionary cash generation. A sustained deficit could reduce financial flexibility, increase reliance on borrowing, and limit the company’s ability to fund expansion or withstand weaker operating conditions.

Japan Animal Referral Medical Center Co., Ltd. (6039) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%40%50%JP:6039-13.91%EWJ+16.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 11.63B
Dividend Yield
1.28%
Average Volume (3M)
60.07K
Price to Earnings (P/E)
13.6
Beta (1Y)
0.96
Revenue Growth
13.65%
EPS Growth
31.54%
Country
Japan
Employees
328
Sector
Consumer Cyclical
Sector Strength
61
Industry
Personal Products & Services

Japan Animal Referral Medical Center Co., Ltd. Business Overview & Revenue Model

Company Description

Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized de...

Japan Animal Referral Medical Center Co., Ltd. Financial Statement Overview

Summary

Revenue has nearly doubled over five years (¥2.85B in FY2021 to ¥5.28B in FY2025) with a further 12.6% increase projected for FY2026 and a 60% jump in EBIT and net income, pointing to emerging operating leverage (Income Statement: 72). The balance sheet is adequate, with deleveraging from 1.56x to 0.84x debt-to-equity and steady equity accumulation, but debt is projected to rise sharply to ¥5.16B in FY2026 and ROE is only moderate at 12.6% (Balance Sheet: 62). Cash flow is the weakest link: operating cash flow is improving (¥1.37B in FY2025), but free cash flow is frequently negative and projected at -¥953M in FY2026 on heavy capex, leaving the company reliant on external financing (Cash Flow: 58).

Income Statement

72Positive

Balance Sheet

62Positive

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue6.36B6.19B5.28B4.27B3.87B2.98B
Gross Profit2.65B2.51B1.81B1.43B1.41B1.07B
EBITDA1.81B1.74B1.29B961.39M996.73M680.27M
Net Income892.85M833.43M520.98M337.22M380.66M286.94M
Balance Sheet
Total Assets11.24B11.31B8.75B8.77B8.58B7.11B
Cash, Cash Equivalents and Short-Term Investments1.25B1.59B1.11B1.34B1.92B1.07B
Total Debt5.16B5.16B3.48B3.86B3.98B3.92B
Total Liabilities6.28B6.43B4.61B4.96B4.87B4.60B
Stockholders Equity4.96B4.88B4.15B3.81B3.71B2.51B
Cash Flow
Free Cash Flow0-953.45M418.70M-141.26M82.62M-44.14M
Operating Cash Flow01.40B1.37B899.78M810.92M557.57M
Investing Cash Flow0-2.49B-994.38M-985.86M-784.07M-1.43B
Financing Cash Flow01.58B-608.03M-392.32M820.59M722.09M

Japan Animal Referral Medical Center Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price939.00

Price Trends

50DMA985.44Negative
100DMA1012.31Negative
200DMA1130.97Negative

Market Momentum

MACD-19.53Negative
RSI45.15Neutral
STOCH78.33Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6039, the sentiment is Negative. The current price of 939.00 is below the 20-day moving average (MA) of 955.95, below the 50-day MA of 985.44, and below the 200-day MA of 1130.97, indicating a bearish trend. The MACD of -19.53 indicates Negative momentum. The RSI at 45.15 is Neutral, neither overbought nor oversold. The STOCH value of 78.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6039.

Japan Animal Referral Medical Center Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:6039 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
JP:6039JP:603960NeutralJPY 13.46B13.59―1.28%13.65%31.54%
JP:9628JP:962858NeutralJPY 25.10B7.53―5.20%――

* Consumer Cyclical Sector Average

Performance Comparison

-20%0%20%40%JP:6039JP:9628Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:6039 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:6039Japan Animal Referral Medical Center Co., Ltd.939.00-187.53-16.65%
JP:9628San Holdings, Inc. (Japan)1096.00-190.51-14.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026